Abstract
The objective is to evaluate resistance between community-acquired urinary tract infections (CAUTI), nosocomialy-acquired urinary tract infections (NAUTI), and empirical therapy adequacy. E. coli is the predominant pathogen of both CAUTI and NAUTI, followed by Klebsiella spp. in NAUTI and Pseudomonas spp. in catheter-associated urinary tract infections. The highest level of general resistance was found among isolates of NAUTI and catheter-associated UTI followed by CAUTI isolates. Absolute or high level resistance for commonly used empirical antimicrobial therapy was found in catheter-associated UTI and NAUTI while resistance among CAUTI was respectable. Patients with NAUTI as well as patients with catheter-associated urinary tract infections have similar resistance and similar microorganisms isolated as a causative agents, and should not be empirically treated unless the clinical emergency requests.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Merle V, Jeanin-Marie G, Hubert B et al (2002) Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. Eur Urol 41:483–489. doi:10.1016/S0302-2838(02)00069-6
Wagenlehner FME, Loibl E, Vogel H et al (2006) Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management. J Antimicrob Agents 28:86–90. doi:10.1016/j.ijantimicag.2006.05.011
Wagenlehner FME, Naber KG (2006) Treatment of bacterial urinary tract infections: presence and future. Eur Urol 49:235–244. doi:10.1016/j.eururo.2005.12.017
Kunin CM (2006) Urinary-catheter-associated infections in elderly. Int J Antimicrob Agents 28:78–81. doi:10.1016/j.ijantimicag.2006.05.013
Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7:342–347
Bouza E, San Juan R, Munoz P et al (2001) On behalf of the co-operative group of the European study group on nosocomial infections (ESGNI). A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003). Clin Microbiol Infect 7:523–531. doi:10.1046/j.1198-743x.2001.00326.x
Richards CL (2004) Urinary tract infections in the frail elderly: issues for diagnosis, treatment and prevention. Int Urol Nephrol 36:457–463. doi:10.1007/s11255-004-4870-6
Johansen TEB, Cek M, Naber K et al (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51:1100–1112. doi:10.1016/j.eururo.2006.08.012
Gastmeier P, Kampf G, Wischnewski N (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38:37–49. doi:10.1016/S0195-6701(98)90173-6
Warren JW (2001) Catheter-associated urinary tract infections. J Antimicrob Agents 17:299–303. doi:10.1016/S0924-8579(00)00359-9
Yeniyol CÖ, Tuna A, Yener H et al (2003) Bacterial colonization of double J stents and bacterial frequency. Int Urol Nephrol 34:199–202. doi:10.1023/A:1023285422278
Akay AF, Aflay U, Gedik A et al (2007) Risk factors for lower urinary tract infection and bacterial stent colonisation in patients with a double J ureteral stent. Int Urol Nephrol 39:95–98. doi:10.1007/s11255-006-9150-1
Agodi A, Barchitta M, Anzaldi A et al (2007) Active surveillance of nosocomial infections in urologic patients. Eur Urol 51:247–254. doi:10.1016/j.eururo.2006.05.027
Metlay JP, Storm BL, Asch DA (2003) Prior antimicrobial drug exposure: a risk factor for trimethoprim– sulfomethoxazole-resistance urinary tract infections. J Antimicrob Chemother 51:963–970. doi:10.1093/jac/dkg146
Kurutepe S, Surukuoglu S, Sezgin C et al (2005) Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998–2003 in Manisa, Turkey. Jpn J Infect Dis 58:159–161
Wright SW, Wrenn KD, Haynes ML (1999) Trimethoprim–sulfomethoxazole resistance among urinary coliform isolates. J Gen Intern Med 14:606–609. doi:10.1046/j.1525-1497.1999.10128.x
Olafson M, Kristinsson KG, Sigurdsson JA (2000) Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs. Scand J Prim Health Care 18:35–38. doi:10.1080/02813430050202532
Nickel JC (2005) Management of urinary tract infections: historical perspective and current strategies part 2-modern menagement. J Urol 173:1–6. doi:10.1097/01.ju.0000159198.83103.01
Drews SJ, Poutanen SM, Mazzulli T et al (2005) Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherischia coli isolates. J Clin Microbiol 43:4218–4220. doi:10.1128/JCM.43.8.4218-4220.2005
Khuri SF, Henderson WG, DePalma RG et al (2005) Participants in the VA National Surgical Quality Improvement. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242:326–341
Burke JP (2003) Infection control—a problem for patient safety. N Engl J Med 348:651–656. doi:10.1056/NEJMhpr020557
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milan, P.B., Ivan, I.M. Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy. Int Urol Nephrol 41, 461–464 (2009). https://doi.org/10.1007/s11255-008-9468-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-008-9468-y